No profile data available.
Jasper Therapeutics, Inc. (JSPR) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Redwood City, United States.
It reported revenue of $0 for fiscal year 2025, and net income of -$75.80 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $18.97 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases.
Jasper Therapeutics reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$18.97 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Vyome Holdings, Inc. (HIND), BeyondSpring Inc. (BYSI), inTerra Resources Corp (ITRX), Zenith Capital Corp. (ZHCLF).